Titan Pharma (TTNP) Misses Q4 EPS by 1c

Titan Pharma (NASDAQ: TTNP) reported Q4 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Titan Pharma (TTNP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M